Quarterly ResultAug 4, 2026, 05:07 PM
Hyster-Yale Q2 Revenue Down 15%; Net Loss Widens to $31.6M
AI Summary
Hyster-Yale, Inc. reported a significant decline in its second-quarter 2026 financial performance, with revenues decreasing by 15% to $812.9 million and net loss attributable to stockholders widening to $31.6 million from $13.9 million in the prior year. The company also experienced an increased operating loss of $18.4 million for the quarter. For the six months ended June 30, 2026, revenues fell by 13.9% to $1,608.1 million, and the net loss expanded substantially to $62.1 million. A discrete tax charge of $3.4 million was recognized due to a valuation allowance against Brazilian deferred tax assets.
Key Highlights
- Q2 2026 revenues decreased 15.0% to $812.9 million from $956.6 million YoY.
- Q2 2026 net loss attributable to stockholders widened to $31.6 million from $13.9 million YoY.
- Basic loss per share for Q2 2026 was $1.76, compared to $0.79 in Q2 2025.
- Six-month 2026 revenues decreased 13.9% to $1,608.1 million from $1,867.0 million YoY.
- Six-month 2026 net loss attributable to stockholders was $62.1 million, up from $5.3 million YoY.
- Cash and cash equivalents decreased to $72.6 million at June 30, 2026, from $123.2 million at Dec 31, 2025.
- Operating loss for Q2 2026 widened to $18.4 million from $8.5 million YoY.
- Recognized a $3.4 million discrete tax charge for Brazilian deferred tax assets in Q2 2026.
Price Impact
More from HY